yes, because those with less-than-advanced financial knowledge (i.e., many investors) will tend to "value" the deal at the "premium to current share price" vs. any multiple used by advisors & potential acquirers...imo. a further decline in pps, imo, decreases overall return for shareholders - PLUS, there's really no justification, given the assets & the AR deal.
KTEAM not long for this board...should be seeking new shorting target(s) NOW...LOLOL!!!! "FAILURE" mode...LOLOLOL!!!! ICAHN IN CONTROL OF #1 E.D. DRUG IN THE WORLD!!!!!???
this go round, STENDRA RETURNS, and SHAREHOLDERS WILL NOT STAND IDLY BY WITH LAME MANAGEMENT OF A SUPER-DRUG with OUTSTANDING POTENTIAL IF MARKETED CORRECTLY!!!! Heads up to the Board of Directors and Executive Team at Vivus that your shareholders are expecting MUCH, MUCH more from you THIS GO ROUND!!!!
I believe ENDP knew AUXL had failed VVUS, and didn't want that to sandbag its acquisition, given the other possibilities for AUXL drugs. I.e., VVUS was going to take too much focus away from others. ENDP simply did not want to make the necessary investment, imo, and their expertise was not urology. so, give it back to Vivus.
that serves as ID for airport security, payments, health care visits/insurance verification, school visits, parking & office building security card, drivers license, etc...the fingerprint is the key. has this technology been mastered yet? last I heard the readers were not fool-proof...anyone?
I think they need to go the security route - parking deck & office building swipes using wearables vs. cards & ID's on lanyards...seems so cumbersome & unnecessary.
seems like a pretty good fit. FIT already made acquisition of payment/transaction company, needs DIGITAL SECURITY next, imo...thoughts? the WEARABLE MARKET IS THE NEXT BIG THING IN RETAIL imo...GPS sensor tracking consumer movement & shopping habits, transactions processing, etc. DMRC should be working with Fitbit, imo.
setting up a promotional subsiidiary is not criminal, imo - in fact, it makes sense for a research/manufacturing operation to establish a "conduit" for getting product to market. nice try, alan, but not sure you've found the silver bullet...lol.
DREAM DRUG for Vivus shareholders, now that - imo - very lame marketing strategy being abandoned!!!!! MANAGEMENT & THE BOARD NEED A PLAN TO EXPOSE THIS DRUG TO THE WORLD!!!!!
more bonus coming for BAGAS...LOLOLOL!!!!!
added more to IRA...for divvy & growth prospects due to health services demand
then, sales figures, feedback on website and more?